Fish oil is promising in the prevention of heart attacks: study



[ad_1]

Fish oil is promising in the prevention of heart attacks: study

Image for illustration purposes only.
Image credit: Pixabay

New York: A new study suggests that vitamin D and omega-3 (fish oil) tests are promising in preventing death from cancer and heart attacks.

The results have been mixed but look promising for some results and are now confirmed by updated meta-analyzes, according to the researchers.

"The results model suggests a complex balance of benefits and risks for each intervention and emphasizes the need for further research to determine which individuals are most likely to derive a net benefit from these supplements," said the researcher. Lead author of the study, JoAnn Manson, of Harvard. University.

Nearly 26,000 men and women from the United States participated in the VITAL national clinical trial.

After more than five years of study and treatment, the results show promising signals for some results.

For example, while omega-3 fatty acids (fish oil) showed only a small, but not significant, reduction in the primary endpoint of cardiovascular evaluation of major cardiovascular events, they were associated with a reduction significant heart attacks.

The most important therapeutic benefits were found in individuals consuming less fish than the median cohort (1.5 servings per week), but not in those consuming above that level.

The benefits to heart health are now confirmed by recent meta-analyzes of randomized trials of omega-3s.

Similarly, vitamin D supplementation did not reduce major cardiovascular events or total cancer incidence, but was associated with a statistically significant reduction in total cancer mortality among those participating in the trial for at least two years. .

The effect of vitamin D on reducing the number of cancer deaths is also confirmed by updated meta-analyzes of vitamin D clinical trials conducted to date.

The study is expected to be presented at the annual North American Menopause Society (NAMS) meeting in Chicago from September 25 to 28.

[ad_2]

Source link